Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Royce & Associates Chuck Royce | 0 | $0 | 0% | |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Hudson Bay Capital Management Sander Gerber | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | Director | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | Director | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | Director | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | Large Shareholder, Director | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | Large Shareholder, Director | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.00 | 17,304 | Officer | 193,601 | 2025-01-24 | Filing | |
| $30.08 | 27,098 | Large Shareholder, Officer, Director | 27,918 | 2025-01-23 | Filing | |
| $28.68 | 4,153 | Officer | 165,650 | 2025-01-21 | Filing | |
| $30.00 | 50,000 | Officer | 169,803 | 2025-01-21 | Filing | |
| $29.72 | 4,476 | Officer | 706,872 | 2025-01-21 | Filing |
Institutional Investors' Holdings
News See All
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.
Here’s Cedar Grove Capital Management’s Investment Thesis for Hims & Hers Health (HIMS)
Cedar Grove Capital Management, an investment management company, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Why Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc (MSTR) Plunged Today
Shares in Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc.
Here's How Eli Lily (LLY) Caused Hims & Hers (HIMS) Stock To Fall
Eli Lily continues to dominate the weight loss market, willing to crush any competitor that threatens its dominance.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on La Newsletter de Momentum’s Substack by Mexican Investor. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers Health, Inc. (NYSE:HIMS) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Hims & Hers Second Quarter 2024 Earnings Conference Call.
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2024 Earnings Call Transcript
Hims & Hers Health, Inc. beats earnings expectations. Reported EPS is $0.04852, expectations were $0.02. Hims & Hers Health, Inc.
Billionaire Hedge Funds
